Natera, Inc. - Common Stock (NQ:NTRA)

204.49 +8.38 (+4.27%)

Streaming Delayed Price Updated: 11:29 AM EDT, Apr 17, 2026 Add to My Watchlist

Price and Volume

Volume	434,110
Open	200.14
Bid (Size)	204.27 (100)
Ask (Size)	204.66 (100)
Prev. Close	196.11
Today's Range	198.28 - 205.48
52wk Range	131.81 - 256.36
Shares Outstanding	139,693,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm

April 15, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma

April 13, 2026

From Natera, Inc.

Via Business Wire

Performance

YTD	-10.6%	-10.6%
1 Month	+3.1%	+3.1%
3 Month	-14.9%	-14.9%
6 Month	+13.3%	+13.3%
1 Year	+36.2%	+36.2%

More News

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

April 09, 2026

Via StockStory

3 Reasons NTRA Has Explosive Upside Potential

April 09, 2026

Via StockStory

Natera Inc. (NASDAQ:NTRA) Crushes Q4 Earnings Estimates with Strong Oncology Growth ↗

February 26, 2026

Via Chartmill

20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform

April 07, 2026

From Natera, Inc.

Via Business Wire

SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery

March 31, 2026

From Natera, Inc.

Via Business Wire

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

March 27, 2026

Via StockStory

Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics

March 23, 2026

Via MarketMinute

1 Unprofitable Stock to Own for Decades and 2 Facing Headwinds

March 20, 2026

Via StockStory

1 Cash-Heavy Stock to Target This Week and 2 We Question

March 19, 2026

Via StockStory

NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

March 16, 2026

Via StockStory

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment ↗

March 16, 2026

Via The Motley Fool

This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock ↗

March 16, 2026

Via The Motley Fool

Two Publications Highlight Clinical Utility of Signatera™ in Anal and Rectal Cancers

March 16, 2026

From Natera, Inc.

Via Business Wire

3 Growth Stocks to Add to Your Roster

March 16, 2026

Via StockStory

3 Market-Beating Stocks to Target This Week

March 13, 2026

Via StockStory

Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis

March 12, 2026

From Natera, Inc.

Via Business Wire

3 Healthcare Stocks to Target This Week

March 09, 2026

Via StockStory

Natera (NTRA) Stock Trades Up, Here Is Why

March 03, 2026

Via StockStory

3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade ↗

February 28, 2026

Via The Motley Fool

Why Natera (NTRA) Shares Are Falling Today

February 27, 2026

Via StockStory

Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation

February 27, 2026

From Natera, Inc.

Via Business Wire

Natera (NTRA) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Natera Reports Fourth Quarter and Full Year 2025 Financial Results

February 26, 2026

From Natera, Inc.

Via Business Wire

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?

Yes, Natera, Inc. - Common Stock is publicly traded.

What exchange does Natera, Inc. - Common Stock trade on?

Natera, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Natera, Inc. - Common Stock?

The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market

What is the current price of Natera, Inc. - Common Stock?

The current price of Natera, Inc. - Common Stock is 204.49

When was Natera, Inc. - Common Stock last traded?

The last trade of Natera, Inc. - Common Stock was at 04/17/26 11:29 AM ET

What is the market capitalization of Natera, Inc. - Common Stock?

The market capitalization of Natera, Inc. - Common Stock is 28.57B

How many shares of Natera, Inc. - Common Stock are outstanding?

Natera, Inc. - Common Stock has 29B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.